份子癌症医治 SCIE

期刊简介估计审稿时候： 约3月

Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.

《份子癌症医治学》将重点存眷对以下范畴癌症医治有影响的根本研讨：尝试癌症医治学、份子靶标辨认、化学防备靶标、新模子、癌症化学和药物发明、份子和细胞药理学、肿瘤的份子分类和生物信息学和计较份子生物学。该期刊为这些新兴学科供给了一个特地针对癌症研讨的出书服装论坛t.vhao.net。论文颠末严酷检查，只要报告新奇、实时和主要研讨功效并合适高迷信代价规范的论文才会被接管颁发。

《Molecular Cancer Therapeutics》(份子癌症医治)编辑部通信体例为AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。